

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:


(Sharecast News) - Specialist contract research organisation hVIVO has successfully manufactured its Omicron human challenge agent, it announced on Th...


(Alliance News) - hVIVO PLC on Monday said it has signed a GBP6.8 million contract with a leading Asia-Pacific pharmaceutical company, to test its res...


(Alliance News) - hVIVO PLC on Wednesday said it expects to report record revenue for 2022, as it reported a strong order book.


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - hVIVO PLC on Wednesday said it signed a GBP5.2 million contract with a "global biotechnology company" headquartered in Asia Pacific ...


(Sharecast News) - Contract research organisation hVIVO has signed a £5.2m contract with a global biotechnology company to test its respiratory s...